// App-Quantinova.ai

: Cabergoline monotherapy in acromegaly – a multicenter, retrospective, cohort study of non-irradiated patients using current criteria for disease control

Researchers

Presenter

  • Sandrine A Urwyler

Principal Investigators

  • Irene Samperi

  • Kirstie Lithgow

  • Akash Mavilakandy

  • Mike Matheou

  • John Ayuk

  • Karin Bradley

  • Aparna Pal

  • Narendra Reddy

  • Niki Karavitaki

Medical Centers

  • Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

  • Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK

  • Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Department of Endocrinology, Birmingham, United Kingdom

  • Department of Diabetes & Endocrinology, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK

  • Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospital NHS Trust, Oxford, United Kingdom

  • Thoracic Surgery, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acromegaly

Biomarkers

  • N/A

Drug/Treatment

  • Cabergoline

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved